Millipore Sigma Vibrant Logo

AB2265 Anti-VPAC1 Antibody

Anti-VPAC1 Antibody detects level of VPAC1 & has been published & validated for use in IH(P) & WB.

Anti-VPAC1 Antibody: Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.
Research Category: Neuroscience Research Sub-Category: Hormones & Receptors Gene Symbol: VIPR1, PACAP-R-2, RCD1, VIP-R-1, VPAC1, VIRG, HVR1, VPCAP1R, VAPC1, VIPR, RDC1 UniProt Number: P97751
View Products on Sigmaaldrich.com
AB2265
100 µg  
Recuperando precio...
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Maximum Quantity is
Al finalizar el pedido Más información
Ahorró ()
 
—
Solicitar precio
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      Ofertas especiales

       

      Póngase en contacto con el Servicio de Atención al Cliente

      Descripción

      Replacement Information

      Ofertas especiales

      100% Performance Guaranteed

      Tabla espec. clave

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, M, RIH(P), WBRbAffinity PurifiedPolyclonal Antibody
      Description
      Catalogue NumberAB2265
      DescriptionAnti-VPAC1 Antibody
      Alternate Names
      • Vasoactive intestinal polypeptide receptor 1
      • Pituitary adenylate cyclase-activating polypeptide type II receptor
      • vasoactive intestinal peptide/pituitary adenylate cyclase activating peptide receptor 1
      Background InformationThe vasoactive intestinal peptide/pituitary adenylate cyclase activating peptide receptor 1 (VPAC1) is a member of a class II subfamily of G-protein-coupled receptors and has a high affinity for vasoactive intestinal peptide (VIP). VPAC1 has been associated with many different lung cancer cell lines. VPAC1 is thought to be activated by FXR and may contribute to the regulation of bile secretion to protect against gallstone disease. VPAC1 could be used to regulate VIPs and, in turn, inhibit breast cancer growth. VPAC1 has also been implicated in regulation of the anti-inflammatory effects of VIP.
      References
      Product Information
      FormatAffinity Purified
      Control
      • SK-OV-3 cell lysate
      PresentationPurified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationAnti-VPAC1 Antibody detects level of VPAC1 & has been published & validated for use in IH(P) & WB.
      Key Applications
      • Immunohistochemistry (Paraffin)
      • Western Blotting
      Application NotesImmunohistochemistry Analysis: 1:500 dilution from a previous lot detected VPAC1 in ovarian carcinoma tissue.
      Biological Information
      ImmunogenKLH-conjugated linear peptide corresponding to the cytoplasmic domain of VPAC1.
      EpitopeCytoplasmic domain
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostRabbit
      SpecificityThis antibody recognizes VPAC1 at the cytoplasmic domain.
      Species Reactivity
      • Human
      • Mouse
      • Rat
      Antibody TypePolyclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • VIPR1
      • PACAP-R-2
      • RCD1
      • VIP-R-1
      • VPAC1
      • VIRG
      • HVR1
      • VPCAP1R
      • VAPC1
      • VIPR
      • RDC1
      Purification MethodAffinity Purfied
      UniProt Number
      UniProt SummaryFUNCTION: This is a receptor for VIP. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.

      SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.

      SEQUENCE SIMILARITIES: Belongs to the G-protein coupled receptor 2 family.
      Molecular Weight~52 kDa observed. Multiple molecular weights of VPAC1 may be due to glycosylation. (Fabre, C, et al. (1993). Peptides. 14:483-489.)
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blot in SK-OV-3 cell lysate.

      Western Blot Analysis: 1 µg/mL of this antibody detected VPAC1 on 10 µg of SK-OV-3 cell lysate.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      AB2265 04053252415692

      Documentation

      Licencias necesarias

      Título
      PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

      Anti-VPAC1 Antibody Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Anti-VPAC1 Antibody Certificados de análisis

      CargoNúmero de lote
      Anti-VPAC1 - 2117155 2117155
      Anti-VPAC1 - 2420583 2420583
      Anti-VPAC1 - 2329172 2329172
      Anti-VPAC1 - 3365215 3365215
      Anti-VPAC1 - 3596842 3596842
      Anti-VPAC1 - 3800128 3800128
      Anti-VPAC1 - 3943323 3943323
      Anti-VPAC1 - NRG1851039 NRG1851039
      Anti-VPAC1 -2514195 2514195
      Anti-VPAC1 -2689635 2689635
      Show more